Prostaglandin E1 as a Screening Vasodilator in Primary Pulmonary Hypertension

Pulmonary vasodilators are variably efficacious in primary pulmonary hypertension (PPH). None has consistently improved hemodynamics enough to obviate the need for complex and potentially hazardous testing of several vasodilators. Prostaglandin E1 (PCE1), a potent, short-acting pulmonary vasodilator...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chest 1987-10, Vol.92 (4), p.686-691
Hauptverfasser:	Halpern, Steven M., Shah, P.K., Lehrman, Stuart, Goldberg, Howard S., Jasper, Alan C., Koerner, Spencer K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Alprostadil - therapeutic use Biological and medical sciences Female Hemodynamics - drug effects Humans Hydralazine - therapeutic use Hypertension, Pulmonary - drug therapy Hypertension, Pulmonary - physiopathology Male Medical sciences Middle Aged Nifedipine - therapeutic use Oxygen - blood Pharmacology. Drug treatments Pulmonary Circulation - drug effects Pulmonary Gas Exchange - drug effects Respiratory system Vasodilator Agents - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!